1
Clinical Trials associated with GSK-5475152 / Active, not recruitingPhase 1/2 A Phase 1/2, Randomized, Controlled Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of an Investigational Flu Seasonal/SARS-CoV-2 Combination mRNA Vaccine in Adults
This study will evaluate the reactogenicity, safety, and immune response of Flu Seasonal/SARS-CoV-2 mRNA (mRNA Flu/COVID-19) combination vaccine. The flu portion will target multiple strains of the flu virus, while the COVID-19 part will focus on the spike protein of the SARS-CoV-2 virus. Both parts of this vaccine have been tested individually before. This will be the first study to test the combined vaccine in humans in healthy adult participants.
100 Clinical Results associated with GSK-5475152
100 Translational Medicine associated with GSK-5475152
100 Patents (Medical) associated with GSK-5475152
100 Deals associated with GSK-5475152